UB Paderborn / Katalog / Suche / in CDI

Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor

Frontiers in oncology, 2022-05, Vol.12, p.864708-864708

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial Comment from Dr Szarvas and Dr Reis to Clinicopathological features of malignant urachal tumor: A hospital‐based cancer registry data in Japan

International journal of urology, 2020-02, Vol.27 (2), p.163-164

2020

Link zum Volltext

Verfügbarkeit prüfen

Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study

European journal of cancer (1990), 2021-09, Vol.154, p.167-174

2021

Link zum Volltext

Verfügbarkeit prüfen

MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer

PloS one, 2016-06, Vol.11 (6), p.e0156871-e0156871

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 cases

Urologic oncology, 2016-09, Vol.34 (9), p.388-398

2016

Link zum Volltext

Verfügbarkeit prüfen

End‐ischemic reconditioning of liver allografts: Controlling the rewarming

Liver transplantation, 2016-09, Vol.22 (9), p.1223-1230

2016

Link zum Volltext

Verfügbarkeit prüfen

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer

International journal of molecular sciences, 2021-07, Vol.22 (14), p.7431

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis

Journal of translational medicine, 2023-02, Vol.21 (1), p.124-124, Article 124

2023

Link zum Volltext

Verfügbarkeit prüfen

MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis

PloS one, 2017-07, Vol.12 (7), p.e0180834

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology

BMC bioinformatics, 2023-01, Vol.24 (1), p.1-1, Article 1

2023

Link zum Volltext

Verfügbarkeit prüfen

Report of the Uropathology Working Group of the German Society for Pathology

Pathologie (Heidelberg, Germany), 2023-12, Vol.44 (Suppl 3), p.260-262

2023

Link zum Volltext

Verfügbarkeit prüfen

Bericht der Arbeitsgemeinschaft Uropathologie der Deutschen Gesellschaft für Pathologie

Die Pathologie, 2023-12, Vol.44 (Suppl 3), p.260-262

2023

Link zum Volltext

Verfügbarkeit prüfen

The Biomarker Potential of Caveolin-1 in Penile Cancer

Frontiers in oncology, 2021-03, Vol.11, p.606122-606122

2021

Link zum Volltext

Verfügbarkeit prüfen

Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy

BMC cancer, 2022-01, Vol.22 (1), p.46-13, Article 46

2022

Link zum Volltext

Verfügbarkeit prüfen

Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens

BMC cancer, 2023-06, Vol.23 (1), p.504-504, Article 504

2023

Link zum Volltext

Verfügbarkeit prüfen

MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy

Clinical lung cancer, 2018-07, Vol.19 (4), p.e441-e463

2018

Link zum Volltext

Verfügbarkeit prüfen

Macrophage activity at the site of tumor ablation can promote murine urothelial cancer via transforming growth factor-β1

Frontiers in immunology, 2023-01, Vol.14, p.1070196-1070196

2023

Link zum Volltext

Verfügbarkeit prüfen

CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients

Scientific reports, 2023-01, Vol.13 (1), p.533-9, Article 533

2023

Link zum Volltext

Verfügbarkeit prüfen

Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer

The Prostate, 2016-08, Vol.76 (11), p.977-985

2016

Link zum Volltext

Verfügbarkeit prüfen

Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer

Pathology international, 2017-12, Vol.67 (12), p.597-601

2017

Link zum Volltext

Verfügbarkeit prüfen

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy

Cancers, 2021-05, Vol.13 (11), p.2548

2021

Link zum Volltext

Verfügbarkeit prüfen

Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI

PloS one, 2015-01, Vol.10 (1), p.e0116277-e0116277

2015

Link zum Volltext

Verfügbarkeit prüfen

Current diagnostic and treatment strategies for urachal cancer

Orvosi hetilap, 2023-04, Vol.164 (16), p.602

2023

Link zum Volltext

Verfügbarkeit prüfen

Active Autophagy Is Associated with Favorable Outcome in Patients with Surgically Resected Cholangiocarcinoma

Cancers, 2023-08, Vol.15 (17), p.4322

2023

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer

PloS one, 2013-11, Vol.8 (11), p.e80084

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor

Editorial Comment from Dr Szarvas and Dr Reis to Clinicopathological features of malignant urachal tumor: A hospital‐based cancer registry data in Japan

Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study

MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer

Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 cases

End‐ischemic reconditioning of liver allografts: Controlling the rewarming

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer

Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis

MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis

Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology

Report of the Uropathology Working Group of the German Society for Pathology

Bericht der Arbeitsgemeinschaft Uropathologie der Deutschen Gesellschaft für Pathologie

The Biomarker Potential of Caveolin-1 in Penile Cancer

Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy

Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens

MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy

Macrophage activity at the site of tumor ablation can promote murine urothelial cancer via transforming growth factor-β1

CT-radiomics and clinical risk scores for response and overall survival prognostication in TACE HCC patients

Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer

Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy

Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI

Current diagnostic and treatment strategies for urachal cancer

Active Autophagy Is Associated with Favorable Outcome in Patients with Surgically Resected Cholangiocarcinoma

Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer

Suchergebnisse filtern